Irfan Cicin

Irfan Cicin

Trakya University - Edirne / Türkiye
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4991853
Trakya Üniversitesi
person_outline Irfan Cicin's MOST POPULAR ARTICLES
1-) Pembrolizumab plus chemotherapy for squamous non–small-cell lung cancer New England journal of medicine 379 (21), 2040-2051, 2018
2-) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised … The Lancet 394 (10212), 1915-1928, 2019
3-) Pembrolizumab for early triple-negative breast cancer New England Journal of Medicine 382 (9), 810-821, 2020
4-) Trastuzumab emtansine for residual invasive HER2-positive breast cancer New England Journal of Medicine 380 (7), 617-628, 2019
5-) Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer New England Journal of Medicine 377 (9), 829-838, 2017